NCT02434042View on ClinicalTrials.gov

Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children

NACompletedINTERVENTIONAL

Enrollment

520

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

February 28, 2016

Study Completion Date

February 28, 2016

Conditions

Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

BB536

Intervention consists of daily administration of 1g probiotic Bifidobacterium longum BB536, administer daily for five days a week at a fixed dosage of 9 log CFU/day for BB536 and continue for 10 months.

OTHER

Placebo

Intervention consists of daily administration of 1g of 100% dextrin, administer daily for five days a week and continue for 10 months.

Trial Locations (1)

11900

School of Industrial Technology, Universiti Sains Malaysia, Pulau Pinang

All Listed Sponsors

collaborator

Morinaga Milk Industry Co., LTD

INDUSTRY

lead

Universiti Sains Malaysia

OTHER

NCT02434042 - Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children | Biotech Hunter | Biotech Hunter